University of Ioannina School of Health Sciences Faculty of Medicine, Department of Ophthalmology, Ioannina, Greece
University of Ioannina School of Health Sciences Faculty of Medicine, Department of Surgery, Ioannina, Greece
Turk J Ophthalmol. 2020 Dec 29;50(6):377-380. doi: 10.4274/tjo.galenos.2020.99836.
This study presents a rare case of unilateral posterior scleritis as an ophthalmic manifestation of a paraneoplastic syndrome. A 61-year-old man presented to our department complaining of gradual worsening of vision in his left eye. Visual acuity was 10/10 and 3/10 in his right and left eye, respectively. He also mentioned that he experienced posterior ocular pain while sleeping at night, but was otherwise asymptomatic. His past ophthalmic and medical history were clear. A thorough clinical, imaging (fundus photography, optical coherence tomography, fluorescein angiography, and B-scan), and laboratory investigation was carried out. A diagnosis of posterior scleritis was made, but no obvious cause or underlying disease was identified even after a thorough systematic assessment. Regular follow-up within the next few months did not reveal any further pathological findings. Finally, 6 months after the initial presentation, the patient was diagnosed with colon cancer. Posterior scleritis can present as an ophthalmic manifestation of a paraneoplastic syndrome in patients with an underlying malignancy, even months before the presentation of systemic symptoms and diagnosis of the underlying disease. In conclusion, in patients (especially older adults) with posterior scleritis, the possibility of a malignant neoplasia must not be ignored or underestimated (paraneoplastic syndrome).
本研究报告了一例罕见的单侧后巩膜炎病例,其为副肿瘤综合征的眼部表现。一名 61 岁男性因左眼视力逐渐下降到我科就诊。右眼和左眼的视力分别为 10/10 和 3/10。他还提到,他在夜间睡觉时感到后眼部疼痛,但除此之外没有其他症状。他过去的眼科和病史均无异常。进行了全面的临床、影像学(眼底照相、光学相干断层扫描、荧光素血管造影和 B 超)和实验室检查。诊断为后巩膜炎,但即使经过全面的系统评估,也未发现明显的原因或潜在疾病。在接下来的几个月内定期随访并未发现任何进一步的病理发现。最后,在初次就诊 6 个月后,患者被诊断为结肠癌。后巩膜炎可在有潜在恶性肿瘤的患者中表现为副肿瘤综合征的眼部表现,甚至在出现全身症状和诊断出潜在疾病之前数月。总之,对于后巩膜炎患者(尤其是老年人),不能忽视或低估恶性肿瘤的可能性(副肿瘤综合征)。